Walgreens Boots Alliance Inc (WBA) : Glenview State Bank Trust Dept. reduced its stake in Walgreens Boots Alliance Inc by 8.58% during the most recent quarter end. The investment management company now holds a total of 60,733 shares of Walgreens Boots Alliance Inc which is valued at $4,814,912 after selling 5,699 shares in Walgreens Boots Alliance Inc , the firm said in a disclosure report filed with the SEC on Apr 25, 2016.Walgreens Boots Alliance Inc makes up approximately 2.93% of Glenview State Bank Trust Dept.’s portfolio.
Walgreens Boots Alliance Inc opened for trading at $79.1 and hit $80.79 on the upside on Monday, eventually ending the session at $80.56, with a gain of 1.61% or 1.28 points. The heightened volatility saw the trading volume jump to 32,50,295 shares. Company has a market cap of $87,025 M.
Other Hedge Funds, Including , Wilbanks Smith Thomas Asset Management boosted its stake in WBA in the latest quarter, The investment management firm added 655 additional shares and now holds a total of 10,551 shares of Walgreens Boots Alliance Inc which is valued at $836,483. Walgreens Boots Alliance Inc makes up approx 0.10% of Wilbanks Smith Thomas Asset Management’s portfolio.Reilly Financial Advisors boosted its stake in WBA in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 4,749 shares of Walgreens Boots Alliance Inc which is valued at $380,585. Walgreens Boots Alliance Inc makes up approx 0.08% of Reilly Financial Advisors’s portfolio.Howland Capital Management reduced its stake in WBA by selling 4,672 shares or 1.55% in the most recent quarter. The Hedge Fund company now holds 296,685 shares of WBA which is valued at $24,162,026. Walgreens Boots Alliance Inc makes up approx 2.43% of Howland Capital Management’s portfolio.Blue Fin Capital reduced its stake in WBA by selling 600 shares or 7.22% in the most recent quarter. The Hedge Fund company now holds 7,714 shares of WBA which is valued at $628,228. Walgreens Boots Alliance Inc makes up approx 0.53% of Blue Fin Capital’s portfolio.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 5, 2016. Analyst had a consensus of $1.28. The company had revenue of $30184.00 million for the quarter, compared to analysts expectations of $30666.29 million. The company’s revenue was up 13.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by Barclays on Mar 10, 2016 to “Equal Weight” and Lowered the Price Target to $ 76 from a previous price target of $81 .Mizuho Upgraded Walgreens Boots Alliance Inc on Mar 1, 2016 to ” Buy”, Price Target of the shares are set at $90.Walgreens Boots Alliance Inc was Initiated by Atlantic Equities to “Neutral” on Feb 3, 2016.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.